Loading clinical trials...
Loading clinical trials...
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy in Hepatic Metastases of Metastatic Colorectal Cancer: a Phase II Multicentric Study With Patients in Progression After First Line Systemic Chemotherapy
Conditions
Interventions
Bevacizumab
Capecitabine
+1 more
Locations
1
France
Institut Gustave Roussy
Villejuif, Val de Marne, France
Start Date
November 1, 2012
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
June 9, 2016
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions